openPR Logo
Press release

Global Nucleic Acid Based Gene Therapy Market | Global Nucleic Acid Based Gene Therapy Industry: Ken Research

01-21-2021 09:19 AM CET | Health & Medicine

Press release from: Ken Research Pvt Ltd

Global Nucleic Acid Based Gene Therapy Market | Global Nucleic

The nucleic acid-based gene therapy market comprises of sales of nucleic acid-based gene therapy products and services. Gene therapy is utilized for correcting defective genes that are accountable for disease improvement. In addition, the nucleic acid-based therapeutics are utilized to treat genetic disorders and diseases for which there prevails no permanent cure such as anaemia, sickle cell, cystic fibrosis, diabetes, and thalassemia.

According to the report analysis, ‘Nucleic Acid Based Gene Therapy Market Global Report 2020-30’ states that the worldwide nucleic acid based gene therapy market was worth USD 557.47 million during 2019. It is projected to increase at a compound annual growth rate (CAGR) of 10.00% and reach USD 816.18 million by 2023. During May 2018, Vectalys, a leading biotechnology corporate specializing in the producing of high-quality solutions for gene delivery and Flash Cell, a corporate engaged in improving the non-integrated lentiviral provided RNA Therapeutics publicized the merger to generate Flash Therapeutics, a privately controlled gene therapy company improving the cell and gene therapeutics. The fresh company Flash Therapeutics is projected to focus on the development of RNA therapeutics dependent on LentiFlash, a non-integrative lentiviral delivery technology for incurable syndromes.

Although, the stringent regulations imposed on gene therapies promotions the price of gene therapies, which in turn limits the requirement for nucleic acid-based gene therapies. The unwarranted regulatory oversights generate an expensive and elongated route for approval growing the expenses. According to Foundation for Economic Education (FEE), dissimilar other drugs permitted or regulated by the Food and Drug Administration (FDA), gene therapies are not only subject to the supervisory structure of FDA, but also the Recombinant DNA Advisory Committee and Office of Biotechnology Activities. Also, as predictable by FEE, a permitted gene therapy drug cost nearly USD 5.0 billion, which is five times developed than that of the average cost of FDA approval. The great cost of gene therapeutics drugs places them beyond the financial reach of the general public. This scenario is projected to limit the market growth of the nucleic acid-based gene therapy market.

Augmenting the financial support by the government and the corporates is projected to drive the requirement for nucleic acid based gene therapy. Nucleic acid therapeutics are analogs of naturally happening acids or proteins accountable for genetic expression. The traditional therapies do not have any medicine for the treatment of diseases likewise cystic fibrosis, hemophilia, sickle cell anaemia, thalassemia, and diabetes.
The Genetic profiling and molecular objective identification form the backbone of such classes of drugs. Nucleic acid medication has superior potential for the cure of these diseases, as they goal the genetic basis of syndromes and have a permanent cure. Growing financial assistance by the government and the corporates dealing in the market for gene therapy is projected to contribute to growing the requirement for nucleic acid-based gene therapies. For instance during October 2019, the USA National Institutes of Health (NIH) announced plans to contribute USD 100 million for the next four years to cure HIV and sickle cell syndrome with gene therapies. The government assist for gene therapies will underwrite to the growth of the market.

For More Information, Click on the Link Below:-

Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications

Ken Research Pvt. Ltd.,
Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49 Gurgaon, Haryana - 122001, India

Ken Research is a Global aggregator and publisher of Market intelligence, equity and economy reports. Ken Research provides business intelligence and operational advisory in 300+ verticals underscoring disruptive technologies, emerging business models with precedent analysis and success case studies. Serving over 70% of fortune 500 companies globally, some of top consulting companies and Market leaders seek Ken Research’s intelligence to identify new revenue streams, customer/ vendor paradigm and pain points and due diligence on competition.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Nucleic Acid Based Gene Therapy Market | Global Nucleic Acid Based Gene Therapy Industry: Ken Research here

News-ID: 2228690 • Views: 775

More Releases from Ken Research Pvt Ltd

SABIC, Ma'aden, Zamil Steel, Tasnee Lead Middle East Metal Working: Ken Research
SABIC, Ma'aden, Zamil Steel, Tasnee Lead Middle East Metal Working: Ken Research
These companies are playing a crucial role in uplifting the trade & manufacturing within the region, keeping sustainable practices in mind In the dynamic landscape of the Middle East, Zamil Steel and Tasnee stand as catalysts, shaping the region's infrastructure and transport arena. With Zamil Steel's prowess in pre-engineered steel products and Tasnee's leadership in metal production, their collaborative efforts are ensuring Middle East region's substantial progress. Amidst these transformative endeavors,
The US Urinary Tract Infection Therapeutics Market is expected to reach ~$2Bn by 2028: Ken Research
The US Urinary Tract Infection Therapeutics Market is expected to reach ~$2Bn by …
The US urinary tract infection therapeutics market is anticipated to grow at a CAGR of ~2% and become a ~USD 2Bn industry by 2028. Currently, this industry has a market size of ~USD1.8 Bn. STORY OUTLINE The rising age of the population is one of the major factor responsible for the growth of the US UTI Therapeutics market. The rise in government expenditure towards the healthcare sector also pose as growth inhibitor for the US
Top 4 US Loan Servicing Companies And Their Strategies In US Loan Servicing Market: Ken Research
Top 4 US Loan Servicing Companies And Their Strategies In US Loan Servicing Mark …
US Loan Servicing Market is growing due to advanced digital practices and technological advancements. The market is loaded with numerous loan servicing companies that offer a variety of services according to today's modern needs. Let's have a look at some of the top companies and their strategies. Story Outline Fiserv Inc.: One of the FORTUNE'S most admired companies of 2023, a leading global technology provider in the financial services industry, pushing innovation
The US Anesthesia Drug market is anticipated to become a ~USD 6.4 Bn Industry by 2028: Ken Research
The US Anesthesia Drug market is anticipated to become a ~USD 6.4 Bn Industry by …
The United States Anesthesia Drug market is predicted to grow at a CAGR of ~4% in the upcoming 5 years as per the findings of Ken Research. STORY OUTLINE Rising surgical procedures in the US are a major factor behind the growth of the US Anesthesia Drug market. Increasing geriatric population typically requires more surgeries which results in demand of the anesthesia drugs thereby accelerating the US Anesthesia Drug market. Technological advancements make the

All 5 Releases

More Releases for Nucleic

Nucleic Acid Testing Market Technological Breakthroughs by 2026
Global Nucleic Acid Testing Market Research Report 2020 is a historical overview and in-depth study on the current & future market of the Nucleic Acid Testing industry. The report represents a basic overview of the market status, competitor segment with a basic introduction of key vendors, top regions, product types and end industries. This report gives a historical overview of the market trends, growth, revenue, capacity, cost structure, and
Nucleic Acid Isolation and Purification Market to be Driven by Rising Demand of …
Nucleic acid isolation and purification is an initial step in molecular biology studies and recombinant DNA techniques. The process of isolation includes mechanical and chemical disruption, enzymatic digestion, while the purification involves combination of extraction/precipitation, chromatography, centrifugation, electrophoresis, and affinity separation. This technique has wide applications in the field of genetic engineering, life science research, forensics and molecular diagnostics. Nucleic acid isolation helps in processing of more sample in less
Nucleic Acid Extractors Market : Global Snapshot by 2025
Nucleic acids are one of several macromolecules found in the body in addition to fats, proteins, and carbohydrates. A nucleic acid is a polymer composed of four nucleotides linked together in a long chain known as polynucleotide. A nucleic acid consists of DNA, RNA, and protein. Nucleic acid extraction and purification is widely used in next generation sequencing, nucleic acid library preparation, gene therapy research and various other areas such
Global Nucleic Acid Market 2017-2025
IndexBox has just published a new report "World: Nucleic Acids And Their Salts - Market Report. Analysis and Forecast to 2025" ( no link?utm_source=opr ). This report is best suitable for you if you: • Are planning to enter a new geographical market and wish to know which one is best for your product • Are planning to enter a new product market and want to have a detailed overview of the market
Nucleic Acid Aptamers Market 2023 By Top Players
Companies mentioned in the research report Some of the prominent companies in the global market for nucleic acid aptamers are Araxis Kits, LLC, Aptamer Sciences, Inc., Aptagen, LLC, Envirologix, Inc., Cytogenix Inc., Mitsui & Co. Inc., and Quest Diagnostics. Global Nucleic Acid Aptamers Market: Overview Aptamers are peptides or oligonucleotide molecules that bond with a specific target molecule. Nucleic acid aptamers are a special class of nucleic acid species created via rounds of
Roche Unlock the Potential of Locked Nucleic Acids
SMi Group are thrilled to have industry expert Dr Bo Rode Hansen, present a special keynote address on harnessing the potential of locked nucleic acids at the 8th annual RNA Therapeutics conference. The established event set to take place on 22nd & 23rd February in Central London, will once again gather a global audience of scientific leaders, KOL's and drug development specialists, providing a focal point to discuss the future of